Loading…
Loading…
RMED (Ra Medical Systems, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
RMED does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RMED and 80,000+ other tickers.
See exactly how RMED's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RMED and 80,000+ other tickers.
Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity…
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is today, August 17, 2023. The Company has reserved the ticker symbol "VTAK" with the NYSE American, and the Company's common stock is expected to begin trading on the NYSE American under its new name and the new trading symbol effective as of the market open on August 18, 2023.
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Entitled "Vessel Closing Device", the patent to be granted is one in a family of six patent applications on file in the US, and in a number of foreign countries, including the European Community, Japan, and China.
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure.
Name change to Catheter Precision, Inc. expected to become effective on August 17, 2023, with trading under new ticker symbol VTAK expected to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / July 31, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is expected to be August 17, 2023. The Company has reserved the ticker symbol "VTAK" with the NYSE American, and the Company's common stock is expected to begin trading on the NYSE American under its new name and the new trading symbol effective as of the market open on August 18, 2023.
FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE American:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting.